Partners Group Holding AG (P2H)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 676.00 |
|---|---|
| 52-week range | 625.80 – 1,180.00 |
| Return, 1 month / 3 months | +1.9% / −6.6% |
| Return, 1 year / 3 years | −32.8% / – |
| Trend | Below its 200-day average |
| RSI (14) | 58 |
| Volatility (1 year) | 34.0% |
| Worst drawdown (1 year) | -43.8% |
| Average daily value traded | 0.36M EUR |
| Dividend yield | 8.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Partners Group Holding is a private markets investment manager based in Zug, Switzerland. The firm invests client money across private equity, private debt, private real estate and infrastructure, building portfolios of unquoted companies and assets. Its customers are mainly institutional investors, such as pension funds, insurance companies and sovereign wealth funds, along with private clients served through partner banks. Partners Group runs funds and tailored investment programmes, and it also provides investment services and advice to these institutional clients around the world.
The shares are listed on the XETRA Stock Exchange in Germany under the code P2H, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Partners Group Holding AG (P2H) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 676.00 on 23 October 2026.
Its price-based Market X-Ray is 34 out of 100 (a weak price profile), ranking 538 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 32.8% and over the last three months it fell 6.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 17 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -18.2% | ||
| From 52-week high | -42.5% | ||
| Momentum | 22 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.6% | ||
| 6-month return | -29.8% | ||
| 12-month return, skipping the last month | -34.1% | ||
| Stability (higher is calmer) | 41 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.8% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.36M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 50 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 8.0% | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.8% |
|---|---|
| 1 month | +1.9% |
| 3 months | −6.6% |
| 6 months | −29.8% |
| 1 year | −32.8% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 688.48 / 826.71 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 13.91 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 May 2026 | CHF 50.3061 |
| 23 May 2025 | CHF 40.2712 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.